WuXi AppTec Co., Ltd. (SHSE:603259) Institutional Owners May Be Pleased With Recent Gains After 9.0% Loss Over the Past Year
A look at the shareholders of WuXi AppTec Co., Ltd. (SHSE:603259) can tell us which group is most powerful. We can see that institutions own the lion's share in the company with 41% ownership. Put a
Wuxi Apptec Initiated With a Buy at Deutsche Bank
Are Robust Financials Driving The Recent Rally In WuXi AppTec Co., Ltd.'s (SHSE:603259) Stock?
WuXi AppTec's (SHSE:603259) stock is up by a considerable 22% over the past three months. Given the company's impressive performance, we decided to study its financial indicators more closely as a c
Worldwide Analytical Laboratory Services Industry to 2029 - Featuring Syneos Health, Cardinal Health, Wuxi Apptec, SGS and Eurofins Scientific Among Others - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Analytical Laboratory Services Market Analysis by Service Type, by Test Type, by End-Users, and by Region - Global Forecast to 2029" report has been added to ResearchAndM
Pharmaceutical Mingkang was selected for the 2022 Dow Jones Sustainable Development World Index
Pharmaceutical Kangde announced today that it was selected for the 2022 Dow Jones Sustainable Development World Index (DJSI World). This selection is a testament to Medtech's strong belief and outstanding performance in integrating environmental, social and governance (ESG) into the company's strategies and operations.
Wuxi Apptec won Frost Sullivan's 2022 Global CRDMO Company of the year Award
Shanghai, Nov. 30 / PRNewswire-Asianet /-- recently, Frost & Sullivan, an authoritative international consultancy, announced the results of the 2022 Best practice Award (Frost & Sullivan Best Practices Awards). Wuxi Apptec won the "2022 Global CRDMO Company of the year Award" for his industry-leading omni-directional, integrated new drug R & D and production enabling platform. This is the sixth year in a row that Wuxi Apptec has been recognized by the agency.
WuXi AppTec Receives 2022 Global Contract Research, Development and Manufacturing Organization Company of the Year Award From Frost & Sullivan
SHANGHAI, Nov. 29, 2022 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services for the pharmaceutical, biotech and medical device industries to advance
As WuXi AppTec Co., Ltd.'s (SHSE:603259)) Market Cap Dropped by CN¥28b, Insiders Who Sold CN¥1.9b Worth of Stock Were Able to Offset Their Losses
Insiders seem to have made the most of their holdings by selling CN¥1.9b worth of WuXi AppTec Co., Ltd. (SHSE:603259) stock at an average sell price of CN¥81.74 during the past year. The company's ma
WuXi AppTec Shares Dive on Shareholders' Plan to Pare Stake
By Yifan Wang Chinese biotech company WuXi AppTec Co. dived Monday after shareholders unveiled plans to sell up to 65 million shares. Shares hit their 10% daily downside limit in Shanghai, while tho
WuXi AppTec Begins Construction of Wuxi STA Pharmaceutical East China R&D Facility
The pharmaceutical leader also signs agreement on Phase V CRDMO ProjectCHANGZHOU, China, Nov. 22, 2022 /PRNewswire/ -- WuXi AppTec recently held the groundbreaking ceremony for its Wuxi STA Pharmace
No Stock Yet